Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Treasury Shares (2017 - 2019)

Historic Treasury Shares for vTv Therapeutics (VTVT) over the last 4 years, with Q4 2019 value amounting to $11667.0.

  • vTv Therapeutics' Treasury Shares fell 4999.79% to $11667.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $11667.0, marking a year-over-year decrease of 4999.79%. This contributed to the annual value of $11667.0 for FY2019, which is 4999.79% down from last year.
  • According to the latest figures from Q4 2019, vTv Therapeutics' Treasury Shares is $11667.0, which was down 4999.79% from $11667.0 recorded in Q3 2019.
  • vTv Therapeutics' 5-year Treasury Shares high stood at $831934.0 for Q3 2015, and its period low was $11667.0 during Q1 2019.
  • Its 4-year average for Treasury Shares is $85533.5, with a median of $23333.0 in 2018.
  • In the last 5 years, vTv Therapeutics' Treasury Shares plummeted by 3333.14% in 2018 and then plummeted by 5000.0% in 2019.
  • Quarter analysis of 4 years shows vTv Therapeutics' Treasury Shares stood at $831934.0 in 2015, then plummeted by 95.79% to $35000.0 in 2017, then crashed by 33.33% to $23333.0 in 2018, then tumbled by 50.0% to $11667.0 in 2019.
  • Its Treasury Shares stands at $11667.0 for Q4 2019, versus $11667.0 for Q3 2019 and $11667.0 for Q2 2019.